Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow-to-Debt Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥227.64 Million could theoretically repay 0% of its total liabilities (CN¥2.29 Billion) in one year. See Zhejiang Jingxin Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Zhejiang Jingxin Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see Zhejiang Jingxin Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. Check how high is Zhejiang Jingxin Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥781.35 Million | CN¥2.25 Billion | ▲ +18.3% |
| 2024 | 0.29x | CN¥726.16 Million | CN¥2.48 Billion | ▼ -13.1% |
| 2023 | 0.34x | CN¥824.69 Million | CN¥2.45 Billion | ▼ -13.7% |
| 2022 | 0.39x | CN¥855.78 Million | CN¥2.19 Billion | ▲ +68.9% |
| 2021 | 0.23x | CN¥365.02 Million | CN¥1.58 Billion | ▼ -21.8% |
| 2020 | 0.30x | CN¥513.21 Million | CN¥1.73 Billion | ▲ +5.9% |
| 2019 | 0.28x | CN¥535.30 Million | CN¥1.91 Billion | ▼ -24.2% |
| 2018 | 0.37x | CN¥523.40 Million | CN¥1.42 Billion | ▼ -10.1% |
| 2017 | 0.41x | CN¥385.01 Million | CN¥938.43 Million | ▲ +40.3% |
| 2016 | 0.29x | CN¥252.69 Million | CN¥864.23 Million | ▲ +37.3% |
| 2015 | 0.21x | CN¥144.69 Million | CN¥679.39 Million | ▼ -32.6% |
| 2014 | 0.32x | CN¥210.49 Million | CN¥666.12 Million | ▲ +44.2% |
| 2013 | 0.22x | CN¥111.03 Million | CN¥506.65 Million | ▲ +92.1% |
| 2012 | 0.11x | CN¥60.28 Million | CN¥528.40 Million | ▼ -29.9% |
| 2011 | 0.16x | CN¥69.41 Million | CN¥426.39 Million | ▲ +72.0% |
| 2010 | 0.09x | CN¥59.55 Million | CN¥629.02 Million | ▼ -57.3% |
| 2009 | 0.22x | CN¥135.38 Million | CN¥610.06 Million | ▲ +381.0% |
| 2008 | 0.05x | CN¥29.98 Million | CN¥649.89 Million | ▲ +137.7% |
| 2007 | -0.12x | CN¥-87.60 Million | CN¥716.18 Million | ▼ -3945.1% |
| 2006 | 0.00x | CN¥-1.45 Million | CN¥478.23 Million | ▼ -101.4% |
| 2005 | 0.22x | CN¥61.82 Million | CN¥279.27 Million | ▲ +523.5% |
| 2004 | 0.04x | CN¥6.43 Million | CN¥181.11 Million | ▼ -86.9% |
| 2003 | 0.27x | CN¥46.18 Million | CN¥170.36 Million | ▼ -28.9% |
| 2002 | 0.38x | CN¥45.50 Million | CN¥119.35 Million | — |